Novartis Stock Surges 5.86% in Two Days as $23 Billion US Investment Boosts Trading Volume to 338th Rank

Novartis (NVS) shares rose 1.80% on April 14, 2025, marking the second consecutive day of gains, with a total increase of 5.86% over the past two days. The trading volume for the day was 2.60 billion, ranking 338th in the market.

Novartis has announced a significant investment of $23 billion in the United States, aiming to expand its manufacturing and research and development (R&D) capabilities. This plan includes the establishment of 10 sites, seven of which are new, and is expected to create approximately 1,000 jobs for Novartis and an additional 4,000 jobs across the U.S. over the next five years. This strategic move is part of Novartis' broader initiative to enhance its domestic production of key medicines, ensuring a more robust and resilient supply chain within the country.

The company's upcoming quarterly earnings report is anticipated to show earnings of $2.06 per share, reflecting a year-over-year increase of 14.4%. Revenues are projected to reach $12.86 billion, an 8.7% rise from the same period last year. These positive financial projections underscore the company's strong performance and growth potential. However, it is important to note that the consensus earnings per share (EPS) estimate for the quarter has been revised downward by 3% over the past 30 days, which could impact investor sentiment and future stock price movements.